Chronic levodopa treatment alters expression and function of dopamine D3 receptor in the MPTP/p mouse model of Parkinson's disease.

Chronic levodopa treatment alters expression and function of dopamine D3 receptor in the MPTP/p mouse model of Parkinson's disease.
复制标题

DOI:
10.1016/j.neulet.2014.11.023
复制
发表时间:
2015-01-12
影响因子:
2.5
通讯作者:
Kuzhikandathil EV
Kuzhikandathil EV
中科院分区:
医学4区
文献类型:
--
作者:
Cote SR;Kuzhikandathil EV

文献摘要

参考文献

被引文献

相似文献

Chronic treatment with levodopa or antipsychotics results in manifestation of side-effects such as dyskinesia which correlates with changes in expression and function of receptors and signaling proteins. Previous studies have suggested a role for the dopamine D3 receptor in Parkinson’s disease (PD) and tardive dyskinesia. Yet the expression and signaling function of D3 receptor in these disorders is not well understood. Here we tested the hypothesis that chronic levodopa treatment alters both expression and function of D3 receptors in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine plus probenecid (MPTP/p) mouse model of PD. drd3-EGFP reporter mice were injected biweekly with saline or MPTP and probenecid for a 5-week period. During the last two weeks of the 5-week period, the mice were administered saline or levodopa twice daily. Locomotor activity was measured during the treatment period. D3 receptor expression was determined by western blot analysis. D3 receptor signaling function was determined at tissue and single cell level by measuring the activation of D3 receptor-mitogen activated protein kinase (MAPK) pathway. The drd3-EGFP mice administered MPTP/p exhibited akinesia/bradykinesia. Expression of D3 receptor protein in the dorsal striatum specifically increased in the MPTP/p-treated mice administered levodopa. In the dorsal striatum of levodopa and MPTP/p-treated drd3-EGFP mice, administration of a D3 receptor-selective dose of agonist, PD128907, failed to activate D3 receptor-MAPK signaling. These results suggest that MPTP-induced lesion and chronic levodopa treatment alters D3 receptor expression and function in the dorsal striatum which could contribute to the development of dyskinesias and other motor side-effects.
DOI: 10.1016/j.neuroscience.2005.08.003
发表时间: 2005-01-01
期刊: NEUROSCIENCE
影响因子: 3.3
作者:
Holmer, HK;Keyghobadi, M;Meshul, CK
通讯作者: Meshul, CK
DOI: 10.1523/jneurosci.0852-07.2007
发表时间: 2007-06-27
影响因子: 5.3
作者:
Santini, Emanuela;Valjent, Emmanuel;Fisone, Gilberto
通讯作者: Fisone, Gilberto
DOI: 10.1016/j.parkreldis.2004.11.005
发表时间: 2005-06-01
影响因子: 4.1
作者:
Guigoni, C;Aubert, I;Bezard, E
通讯作者: Bezard, E
DOI: 10.1038/nm875
发表时间: 2003-06-01
期刊: NATURE MEDICINE
影响因子: 82.9
作者:
Bézard, E;Ferry, S;Sokoloff, P
通讯作者: Sokoloff, P
DOI: 10.1016/s0306-4522(02)00548-1
发表时间: 2003-01-01
期刊: NEUROSCIENCE
影响因子: 3.3
作者:
Van Kampen, JM;Stoessl, AJ
通讯作者: Stoessl, AJ